Geron Corp
Geron Corp (GERN) Historical Volatility
GERN's 30 day historical volatility is 91.63%, in the 100th percentile of readings over the past year. This is a high percentile, meaning Geron Corp shares have swung far more than usual. GERN's 30 day implied volatility sits at 114.46%, with an IV Rank of 34.13%, leaving IV 22.83 points above historical volatility. This means options are pricing in more movement than the stock has actually delivered, as of Nov 18, 2026.
Read more
Tracking GERN historical volatility helps you see how much Geron Corp's stock price has actually moved, giving you a baseline for whether option premiums look fair, cheap, or expensive. While implied volatility shows what the market expects, GERN's HV, also known as realized volatility, shows what actually happened. Use our scanner to monitor GERN 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.
Historical volatility is the annualized standard deviation of a stock's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. GERN's 30 day historical volatility, or GERN HV, is one of the most widely watched readings because it balances responsiveness with stability. Comparing GERN's HV to its implied volatility reveals the volatility risk premium. When IV sits well above HV, options are pricing in more movement than the stock has actually delivered, giving option sellers an edge. When HV runs hot relative to IV, options are pricing in less movement than the stock has delivered, and buyers may be underpaying for it.
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.
Historical Volatility
Historical movement is elevated versus the past year. The stock has been unusually active.
As of Nov 18, 2026
As of Nov 18, 2026
As of Nov 18, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →